15.05.2024, 20:09
Ecuy Corporate corner: Standard Chartered partners with Turkish Airlines
ISLAMABAD:A local court on Monday granted bail to former senate chairperson Nayyer Hussain Bokhari and his son Jarar Hussain in a police adidas campus verde man assault case.The Margalla police booked Bokhari and his son for assaulting a police official after he had tried to frisk the former senate chairperson at one of the gates of the district courts on May 4.The police obtained arrest warrants for Bokhari from a judicial magistrate on May 5.The former senate chairman and h stanley brand is son, however, obtained a 10-day interim bail from a sessions court on May 6. The suspects appeared before Additional District and Sessions Judge Raja Asif Mehmood on Monday who confirmed their bail.Assistant Sub-inspector Javaid Sultan, who is investiga nb 530 tion officer of the case, said that investigation was underway in the case.He said that the police would soon submit a charge-sheet in the court.Legal experts said that the case against Bokhari could come to an end, if he reconciled with the complainant and convinced him to withdraw t ARIAD Pharmaceuticals, Inc. has announced preliminary clinical data from an ongoing Phase 1 clinical trial of its investigational, multi-targeted kinase inhibitor, AP24534, in patients with advanced hematological cancers.The study results provide initial clinical evidence of hematologic, cytogenetic and molecular anti-cancer activity of AP24534 in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML), including those with the T315I mu yeezys slide tant variant of the target protein, Bcr-Abl. An abstract describing these data is being submitted for yeezys presentation at a major hematology meeting to be held later this year.Treatment of CML or Philadelphia chromosome positive acute lymphoblastic leukem yeezy femme ia (Ph+ ALL) with Bcr-Abl inhibitors is effective in most patients but frequently results in the emergence of Bcr-Abl mutations that confer drug resistance over time. The T315I mutant of Bcr-Abl currently accounts for approximately 15 to 20 percent of all drug-resistant cases
ISLAMABAD:A local court on Monday granted bail to former senate chairperson Nayyer Hussain Bokhari and his son Jarar Hussain in a police adidas campus verde man assault case.The Margalla police booked Bokhari and his son for assaulting a police official after he had tried to frisk the former senate chairperson at one of the gates of the district courts on May 4.The police obtained arrest warrants for Bokhari from a judicial magistrate on May 5.The former senate chairman and h stanley brand is son, however, obtained a 10-day interim bail from a sessions court on May 6. The suspects appeared before Additional District and Sessions Judge Raja Asif Mehmood on Monday who confirmed their bail.Assistant Sub-inspector Javaid Sultan, who is investiga nb 530 tion officer of the case, said that investigation was underway in the case.He said that the police would soon submit a charge-sheet in the court.Legal experts said that the case against Bokhari could come to an end, if he reconciled with the complainant and convinced him to withdraw t ARIAD Pharmaceuticals, Inc. has announced preliminary clinical data from an ongoing Phase 1 clinical trial of its investigational, multi-targeted kinase inhibitor, AP24534, in patients with advanced hematological cancers.The study results provide initial clinical evidence of hematologic, cytogenetic and molecular anti-cancer activity of AP24534 in heavily pretreated patients with resistant and refractory chronic myeloid leukemia (CML), including those with the T315I mu yeezys slide tant variant of the target protein, Bcr-Abl. An abstract describing these data is being submitted for yeezys presentation at a major hematology meeting to be held later this year.Treatment of CML or Philadelphia chromosome positive acute lymphoblastic leukem yeezy femme ia (Ph+ ALL) with Bcr-Abl inhibitors is effective in most patients but frequently results in the emergence of Bcr-Abl mutations that confer drug resistance over time. The T315I mutant of Bcr-Abl currently accounts for approximately 15 to 20 percent of all drug-resistant cases